{
  "drug_name": "Dalbavancin",
  "url": "https://wikem.org/wiki/Dalbavancin",
  "scraped_at": "2026-01-10T07:51:30.728261",
  "sections": {
    "Administration": {
      "text": "Type:\nAntibiotic\nDosage Forms: 500 mg/vial; reconstituted concentration 20 mg/ml\nRoutes of Administration: Intravenous\nCommon Trade Names: Dalvance",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Antibiotic",
          "url": "https://wikem.org/wiki/Antibiotic"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "1500 mg as single dose or 1000 mg then 500 mg one week later; infuse over 30 minutes",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "Safety and efficacy not established in pediatric patients",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "",
      "subsections": {
        "Pregnancy_Rating": {
          "text": "Maternal risk cannot be ruled out",
          "tables": []
        },
        "Lactation_risk": {
          "text": "Fetal risk cannot be ruled out",
          "tables": []
        },
        "Renal_Dosing": {
          "text": "CrCl less than 30 mL/min and not receiving hemodialysis: Single-dose regimen, 1125 mg IV infusion; 2-dose regimen, 750 mg IV infusion followed by 375 mg IV infusion 1 week later\n[1]\nNo adjustment necessary if on\nhemodialysis",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "Hepatic impairment, mild (Child-Pugh class A): No adjustment necessary\nHepatic impairment, moderate to severe (Child-Pugh class B or C): Appropriate dosage has not been determined",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "hemodialysis",
          "url": "https://wikem.org/wiki/Hemodialysis"
        }
      ]
    },
    "Pregnancy_Rating": {
      "text": "Maternal risk cannot be ruled out",
      "subsections": {
        "Lactation_risk": {
          "text": "Fetal risk cannot be ruled out",
          "tables": []
        },
        "Renal_Dosing": {
          "text": "CrCl less than 30 mL/min and not receiving hemodialysis: Single-dose regimen, 1125 mg IV infusion; 2-dose regimen, 750 mg IV infusion followed by 375 mg IV infusion 1 week later\n[1]\nNo adjustment necessary if on\nhemodialysis",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "Hepatic impairment, mild (Child-Pugh class A): No adjustment necessary\nHepatic impairment, moderate to severe (Child-Pugh class B or C): Appropriate dosage has not been determined",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "hemodialysis",
          "url": "https://wikem.org/wiki/Hemodialysis"
        }
      ]
    },
    "Lactation_risk": {
      "text": "Fetal risk cannot be ruled out",
      "subsections": {
        "Renal_Dosing": {
          "text": "CrCl less than 30 mL/min and not receiving hemodialysis: Single-dose regimen, 1125 mg IV infusion; 2-dose regimen, 750 mg IV infusion followed by 375 mg IV infusion 1 week later\n[1]\nNo adjustment necessary if on\nhemodialysis",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "Hepatic impairment, mild (Child-Pugh class A): No adjustment necessary\nHepatic impairment, moderate to severe (Child-Pugh class B or C): Appropriate dosage has not been determined",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "hemodialysis",
          "url": "https://wikem.org/wiki/Hemodialysis"
        }
      ]
    },
    "Renal_Dosing": {
      "text": "CrCl less than 30 mL/min and not receiving hemodialysis: Single-dose regimen, 1125 mg IV infusion; 2-dose regimen, 750 mg IV infusion followed by 375 mg IV infusion 1 week later\n[1]\nNo adjustment necessary if on\nhemodialysis",
      "subsections": {
        "Hepatic_Dosing": {
          "text": "Hepatic impairment, mild (Child-Pugh class A): No adjustment necessary\nHepatic impairment, moderate to severe (Child-Pugh class B or C): Appropriate dosage has not been determined",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "hemodialysis",
          "url": "https://wikem.org/wiki/Hemodialysis"
        }
      ]
    },
    "Hepatic_Dosing": {
      "text": "Hepatic impairment, mild (Child-Pugh class A): No adjustment necessary\nHepatic impairment, moderate to severe (Child-Pugh class B or C): Appropriate dosage has not been determined",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Contraindications": {
      "text": "Allergy to class/drug",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Gastrointestinal:\nClostridium difficile\ncolitis (<2%), Clostridium difficile diarrhea,\nGI bleed\n(<2% )\nHepatic: ALT/SGPT level raised (0.8%)\nImmunologic: Hypersensitivity reaction",
          "tables": []
        },
        "Common": {
          "text": "Gastrointestinal:\nDiarrhea\n(Up to 4.4%), Nausea (Up to 5.5%)\nNeurologic: Headache (Up to 4.7%)",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Clostridium difficile",
          "url": "https://wikem.org/wiki/Clostridium_difficile"
        },
        {
          "text": "GI bleed",
          "url": "https://wikem.org/wiki/GI_bleed"
        },
        {
          "text": "Diarrhea",
          "url": "https://wikem.org/wiki/Diarrhea"
        }
      ]
    },
    "Serious": {
      "text": "Gastrointestinal:\nClostridium difficile\ncolitis (<2%), Clostridium difficile diarrhea,\nGI bleed\n(<2% )\nHepatic: ALT/SGPT level raised (0.8%)\nImmunologic: Hypersensitivity reaction",
      "subsections": {
        "Common": {
          "text": "Gastrointestinal:\nDiarrhea\n(Up to 4.4%), Nausea (Up to 5.5%)\nNeurologic: Headache (Up to 4.7%)",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Clostridium difficile",
          "url": "https://wikem.org/wiki/Clostridium_difficile"
        },
        {
          "text": "GI bleed",
          "url": "https://wikem.org/wiki/GI_bleed"
        },
        {
          "text": "Diarrhea",
          "url": "https://wikem.org/wiki/Diarrhea"
        }
      ]
    },
    "Common": {
      "text": "Gastrointestinal:\nDiarrhea\n(Up to 4.4%), Nausea (Up to 5.5%)\nNeurologic: Headache (Up to 4.7%)",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Diarrhea",
          "url": "https://wikem.org/wiki/Diarrhea"
        }
      ]
    },
    "Pharmacology": {
      "text": "Half-life: 8.5 days\nMetabolism:\nExcretion: Fecal (20%), Renal (33%)",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Semisynthetic lipoglycopeptide antibacterial agent that inhibits cell wall peptidoglycan cross-linking\nSame MOA and class as\nvancomycin",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "vancomycin",
          "url": "https://wikem.org/wiki/Vancomycin"
        }
      ]
    },
    "See_Also": {
      "text": "Antibiotics (Main)\nAntibiotics by diagnosis\nAntibiotics by organism",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Antibiotics (Main)",
          "url": "https://wikem.org/wiki/Antibiotics_(Main)"
        },
        {
          "text": "Antibiotics by diagnosis",
          "url": "https://wikem.org/wiki/Antibiotics_by_diagnosis"
        },
        {
          "text": "Antibiotics by organism",
          "url": "https://wikem.org/wiki/Antibiotics_by_organism"
        }
      ]
    }
  }
}